PMID- 15457681 OWN - NLM STAT- MEDLINE DCOM- 20050818 LR - 20170214 IS - 0956-3202 (Print) IS - 0956-3202 (Linking) VI - 15 IP - 4 DP - 2004 Jul TI - Isothiazole derivatives as novel HIV replication inhibitors. PG - 201-5 AB - A series of 3,4,5-trisubstituted isothiazoles has been screened against HIV-1 (IIIB) and HIV-2 (ROD) at sub-toxic concentrations in acutely infected MT-4 cells. Among the tested compounds, only 3-mercapto-5-phenyl-4-isothiazolecarbonitrile was found to inhibit the replication of HIV-1 (IIIB) and HIV-2 (ROD) at 50% effective concentrations (EC50) of 7.8 and 9.7 microg/ml, respectively. The presence of a thioalkyl chain or dialkylamino function in the 3-position caused a loss of anti-HIV activity. New 4-cyano-5-phenylisothiazoles with other substituents in the 3-position have also been synthesized and studied as potential anti-HIV agents. Our results have demonstrated that 5-phenyl-3-(4-cyano-5-phenylisothiazol-3-yl) disulphanyl-4-isothiazolecarbonitrile and S-(4-cyano-5-phenylisothiazol-3-yl)-O-ethyl thiocarbonate are effective against both HIV-1 (IIIB) (EC50=13.6 and 15.2 microg/ml, respectively) and HIV-2 (ROD) (EC50=17.4 and 13.4 microg/ml, respectively). FAU - Cutri, Christian C C AU - Cutri CC AD - Department of Pharmaceutical Sciences, University of Catania, Catania, Italy. FAU - Garozzo, Adriana AU - Garozzo A FAU - Pannecouque, Christophe AU - Pannecouque C FAU - Castro, Angelo AU - Castro A FAU - Guerrera, Francesco AU - Guerrera F FAU - De Clercq, Erik AU - De Clercq E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Antivir Chem Chemother JT - Antiviral chemistry & chemotherapy JID - 9009212 RN - 0 (5-phenyl-3-(4-cyano-5-phenylisothiazol-3-yl)disulfanyl-4-isothiazolecarbonitrile) RN - 0 (Anti-HIV Agents) RN - 0 (Disulfides) RN - 0 (S-(4-cyano-5-phenylisothiazol-3-yl)-O-ethyl thiocarbonate) RN - 0 (Thiazoles) SB - IM MH - Anti-HIV Agents/chemical synthesis/*chemistry/*pharmacology MH - Cell Line MH - Disulfides MH - HIV-1/*drug effects/physiology MH - HIV-2/*drug effects/physiology MH - Humans MH - Molecular Structure MH - Thiazoles/chemical synthesis/*chemistry/*pharmacology MH - Virus Replication/*drug effects EDAT- 2004/10/02 05:00 MHDA- 2005/08/19 09:00 CRDT- 2004/10/02 05:00 PHST- 2004/10/02 05:00 [pubmed] PHST- 2005/08/19 09:00 [medline] PHST- 2004/10/02 05:00 [entrez] AID - 10.1177/095632020401500403 [doi] PST - ppublish SO - Antivir Chem Chemother. 2004 Jul;15(4):201-5. doi: 10.1177/095632020401500403.